Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein.

The interaction between the endocytic receptor low density lipoprotein receptor-related protein (LRP) and either coagulation factor IX or its active derivative factor IXa was studied. Purified factor IX was unable to associate with LRP when analyzed by surface plasmon resonance. By contrast, factor XIa-mediated conversion of factor IX into factor IXa resulted in reversible dose- and calcium-dependent binding to LRP. Active-site blocking of factor IXa did not affect binding to LRP, whereas LRP binding was efficiently inhibited in the presence of heparin or antibodies against factor IX or LRP. The factor IXa-LRP interaction could be described by a 2-site binding model with equilibrium dissociation constants of 27 nmol/L and 69 nmol/L. Consistent with this model, it was observed that factor IXa binds to 2 different recombinant receptor fragments of LRP (denoted cluster II and cluster IV) with equilibrium dissociation constants of 227 nmol/L and 53 nmol/L, respectively. The amount of factor IXa degraded by LRP-deficient cells was 35% lower than by LRP-expressing cells, demonstrating that LRP contributes to the transport of factor IXa to the intracellular degradation pathway. Because ligand binding to LRP is often preceded by binding to proteoglycans, the contribution of proteoglycans to the catabolism of factor IXa was addressed by employing proteoglycan-deficient cells. Degradation of factor IXa by proteoglycan-deficient cells proceeded at a 83% lower rate than wild-type cells. In conclusion, the data presented here indicate that both LRP and proteoglycans have the potential to contribute to the catabolism of factor IXa.

[1]  I. Mikhailenko,et al.  Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism* , 1999, The Journal of Biological Chemistry.

[2]  A. V. van Zonneveld,et al.  The Second and Fourth Cluster of Class A Cysteine-rich Repeats of the Low Density Lipoprotein Receptor-related Protein Share Ligand-binding Properties* , 1999, The Journal of Biological Chemistry.

[3]  J. V. van Mourik,et al.  The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein* , 1999, The Journal of Biological Chemistry.

[4]  A. V. van Zonneveld,et al.  The second and fourth cluster of class a cysteinerich repeats of the low density lipoprotein receptor-related protein (LRP) share ligandbinding properties* , 1999 .

[5]  J. Gliemann,et al.  Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. , 1998, Biological chemistry.

[6]  H. Pannekoek,et al.  Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor , 1998 .

[7]  J. Miletich,et al.  The low-density lipoprotein receptor-related protein (LRP) mediates clearance of coagulation factor Xa in vivo. , 1998, Blood.

[8]  R. Iozzo,et al.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. , 1997, The Journal of clinical investigation.

[9]  A. V. van Zonneveld,et al.  Molecular Analysis of Ligand Binding to the Second Cluster of Complement-type Repeats of the Low Density Lipoprotein Receptor-related Protein , 1997, The Journal of Biological Chemistry.

[10]  M. Ishihara Animal Cell Mutants Defective in Glycosaminoglycan Biosynthesis , 1997 .

[11]  A. Minton,et al.  Kinetic analysis of biosensor data: elementary tests for self-consistency. , 1996, Trends in biochemical sciences.

[12]  M. Shakibaei,et al.  Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans , 1996, The Journal of experimental medicine.

[13]  J. van den Born,et al.  Identification of the endothelial cell binding site for factor IX. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Strickland,et al.  Cellular Internalization and Degradation of Antithrombin III-Thrombin, Heparin Cofactor II-Thrombin, and -Antitrypsin-Trypsin Complexes Is Mediated by the Low Density Lipoprotein Receptor-related Protein (*) , 1996, The Journal of Biological Chemistry.

[15]  P. Lenting,et al.  The Sequence GluLys of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX (*) , 1996, The Journal of Biological Chemistry.

[16]  B. Hyman,et al.  LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation , 1995, Cell.

[17]  J. V. van Mourik,et al.  Cleavage at Arginine 145 in Human Blood Coagulation Factor IX Converts the Zymogen into a Factor VIII Binding Enzyme (*) , 1995, The Journal of Biological Chemistry.

[18]  S. Leppla,et al.  Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein [published erratum appears in J Cell Biol 1995 Aug;130(4):1015] , 1995, The Journal of cell biology.

[19]  I. Mikhailenko,et al.  Low Density Lipoprotein Receptor-related Protein/-Macroglobulin Receptor Mediates the Cellular Internalization and Degradation of Thrombospondin , 1995, The Journal of Biological Chemistry.

[20]  D. Strickland,et al.  The Cellular Internalization and Degradation of Hepatic Lipase Is Mediated by Low Density Lipoprotein Receptor-related Protein and Requires Cell Surface Proteoglycans (*) , 1995, The Journal of Biological Chemistry.

[21]  J. Baron,et al.  The Molecular Basis of Blood Diseases , 1994 .

[22]  D. Lawrence,et al.  Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. , 1994, The Journal of biological chemistry.

[23]  A. Schwartz,et al.  The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Mertens,et al.  The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes , 1994, British journal of haematology.

[25]  Raymond,et al.  Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. , 1993, The Journal of clinical investigation.

[26]  J. Henkin,et al.  Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. , 1993, The Journal of biological chemistry.

[27]  M. Waknitz,et al.  Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. , 1993, The Journal of biological chemistry.

[28]  D. Cines,et al.  Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells. , 1993, The Journal of biological chemistry.

[29]  D. Bilheimer,et al.  Insulin stimulates receptor-mediated uptake of apoE-enriched lipoproteins and activated alpha 2-macroglobulin in adipocytes. , 1993, The Journal of biological chemistry.

[30]  A. Schwartz,et al.  Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Sambrook,et al.  Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Moestrup,et al.  Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. , 1992, The Journal of biological chemistry.

[33]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[34]  S. Moestrup,et al.  Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. , 1991, The Journal of biological chemistry.

[35]  D. Strickland,et al.  The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin , 1990, The Journal of cell biology.

[36]  S. K. Moestrup,et al.  Purification of the human placental α2‐macroglobulin receptor , 1989 .

[37]  M. Griffith,et al.  Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors. , 1983, The Journal of clinical investigation.

[38]  M. Drillings,et al.  Binding of factors IX and IXa to cultured vascular endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Schwartz,et al.  Binding of coagulation factors IX and X to the endothelial cell surface. , 1983, Biochemical and biophysical research communications.

[40]  H. Jörnvall,et al.  The Active Site Of Antithrombin. Release Of The Same Proteolytically Cleaved Form Of The Inhibitor From Complexes With Factor IXa, Factor Xa And Thrombin , 1982, Thrombosis and Haemostasis.

[41]  K. Fujikawa,et al.  Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom. , 1978, The Journal of biological chemistry.

[42]  E. Davie,et al.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. , 1977, Biochemistry.

[43]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[44]  K. Fujikawa,et al.  The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). , 1974, Biochemistry.

[45]  R. Mahley,et al.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.

[46]  K. Mann,et al.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes. , 1990, Blood.

[47]  S. Moestrup,et al.  Purification of the human placental alpha 2-macroglobulin receptor. , 1989, FEBS letters.

[48]  G. Stamatoyannopoulos,et al.  The molecular basis of blood diseases , 1987 .